AG2R La Mondiale Gestion d'Actifs’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
7,948
+795
+11% +$165K 0.06% 306
2026
Q1
$1.61M Buy
7,153
+95
+1% +$23.7K 0.07% 260
2025
Q4
$1.7M Buy
7,058
+288
+4% +$73.7K 0.08% 243
2025
Q3
$1.75M Hold
6,770
0.09% 215
2025
Q2
$1.75M Buy
6,770
+448
+7% +$107K 0.09% 215
2025
Q1
$1.55M Buy
+6,322
New +$1.48M 0.08% 231

Other funds holding RMD

AG2R La Mondiale Gestion d'Actifs's RMD Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its ResMed (RMD) stake by 11% in Q2 2026, buying an estimated $165K and bringing the position to 7,948 shares worth $1.55M. The position accounts for 0.06% of the portfolio, ranked #306.

AG2R La Mondiale Gestion d'Actifs first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.75M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 7,948 shares of ResMed worth $1.55M as of Q2 2026.
  • AG2R La Mondiale Gestion d'Actifs bought 795 ResMed shares in Q2 2026, an estimated $165K.
  • ResMed made up 0.06% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #306 holding.
  • AG2R La Mondiale Gestion d'Actifs first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • AG2R La Mondiale Gestion d'Actifs's ResMed position peaked at $1.75M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.